Ex-Lab Owner Admits To Selling Unapproved Stem Cells

Law360, New York (August 18, 2011, 9:10 PM EDT) -- The former owner of Arizona-based stem cell distributor Global Laboratories LLC pled guilty Thursday in Texas federal court to charges of introducing stem cells to market without approval from the U.S. Food and Drug Administration.

Fredda Branyon, who owned both Global Laboratories and New Hope Medical Center in Scottsdale, Ariz., pled guilty to one count of introducing an unapproved new drug — the stem cells derived from umbilical cord blood — into interstate commerce.

According to prosecutors, Branyon sold stem cells that were not created under...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.